The DOI matches its Crossref record; 148 of the 148 references it cites were found in a registry or an index.
Targeting the CD40-CD40L pathway in autoimmune diseases: Humoral immunity and beyond
Open accessAbstract
CD40 is a TNF receptor superfamily member expressed on both immune and non-immune cells. Interactions between B cell-expressed CD40 and its binding partner, CD40L, predominantly expressed on activated CD4+ T cells, play a critical role in promoting germinal center formation and the production of class-switched antibodies. Non-hematopoietic cells expressing CD40 can also engage CD40L and trigger a pro-inflammatory response. This article will highlight what is known about the biology of the CD40-CD40L axis in humans and describe the potential contribution of CD40 signaling on both hematopoietic and non-hematopoietic cells to autoimmune disease pathogenesis. Additionally, novel therapeutic approaches to target this pathway, currently being evaluated in clinical trials, are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular mechanisms of T cell co-stimulation and co-inhibition
Chen, L., & Flies, D. B. (2013) · Nature Reviews Immunology · doi:10.1038/nri3405 · Cited by 3,114
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
Henn, V., Slupsky, J. R., Gräfe, M., Anagnostopoulos, I., Förster, R., Müller-Berghaus, G., & Kroczek, R. A. (1998) · Nature · doi:10.1038/35393 · Cited by 2,078
Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells.
Macatonia, S. E., Hosken, N. A., Litton, M., Vieira, P., Hsieh, C. S., Culpepper, J. A., Wysocka, M., Trinchieri, G., Murphy, K. M., & O'Garra, A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.10.5071 · Cited by 1,524
van Kooten, C., & Banchereau, J. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.1.2 · Cited by 1,404
Kawabe, T., Naka, T., Yoshida, K., Tanaka, T., Fujiwara, H., Suematsu, S., Yoshida, N., Kishimoto, T., & Kikutani, H. (1994) · Immunity · doi:10.1016/1074-7613(94)90095-7 · Cited by 1,108
Molecular and biological characterization of a murine ligand for CD40
Armitage, R. J., Fanslow, W. C., Strockbine, L., Sato, T. A., Clifford, K. N., Macduff, B. M., Anderson, D. M., Gimpel, S. D., Davis-Smith, T., Maliszewski, C. R., et al. (1992) · Nature · doi:10.1038/357080a0 · Cited by 1,022
Aruffo, A., Farrington, M., Hollenbaugh, D., Li, X., Milatovich, A., Nonoyama, S., Bajorath, J., Grosmaire, L. S., Stenkamp, R., Neubauer, M., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90668-g · Cited by 814
Noelle, R. J., Roy, M., Shepherd, D. M., Stamenkovic, I., Ledbetter, J. A., & Aruffo, A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.14.6550 · Cited by 804
The CD40/CD154 receptor/ligand dyadRID="†"ID="†" Review
Schönbeck*RID="*"ID="*" Correspondi, U., & Libby, P. (2001) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/pl00000776 · Cited by 737
Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM
Korthäuer, U., Graf, D., Mages, H. W., Brière, F., Padayachee, M., Malcolm, S., Ugazio, A. G., Notarangelo, L. D., Levinsky, R. J., & Kroczek, R. A. (1993) · Nature · doi:10.1038/361539a0 · Cited by 721
CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM
DiSanto, J. P., Bonnefoy, J. Y., Gauchatt, J. F., Fischer, A., & Saint Basile, G. D. (1993) · Nature · doi:10.1038/361541a0 · Cited by 704
Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand
Kawai, T., Andrews, D., Colvin, R. B., Sachs, D. H., & Cosimi, A. B. (2000) · Nature Medicine · doi:10.1038/72162 · Cited by 692
IL-21 Induces Differentiation of Human Naive and Memory B Cells into Antibody-Secreting Plasma Cells
Ettinger, R., Sims, G. P., Fairhurst, A.-M., Robbins, R., da Silva, Y. S., Spolski, R., Leonard, W. J., & Lipsky, P. E. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.7867 · Cited by 675
Self-citationClinical spectrum of X-linked hyper-IgM syndrome
Levy, J., Espanol-Boren, T., Thomas, C., Fischer, A., Tovo, P., Bordigoni, P., Resnick, I., Fasth, A., Baer, M., Gomez, L., et al. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70123-9 · Cited by 655
Boumpas, D. T., Furie, R., Manzi, S., Illei, G. G., Wallace, D. J., Balow, J. E., Vaishnaw, A., & on behalf of the BG9588 Lupus Nephritis Trial Group (2003) · Arthritis & Rheumatism · doi:10.1002/art.10856 · Cited by 618
Ranheim, E. A., & Kipps, T. J. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.4.925 · Cited by 580
Desai-Mehta, A., Lu, L., Ramsey-Goldman, R., & Datta, S. K. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118643 · Cited by 517
Hollenbaugh, D., Grosmaire, L. S., Kullas, C. D., Chalupny, N. J., Braesch-Andersen, S., Noelle, R. J., Stamenkovic, I., Ledbetter, J. A., & Aruffo, A. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05530.x · Cited by 511
Karmann, K., Hughes, C. C., Schechner, J., Fanslow, W. C., & Pober, J. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4342 · Cited by 472
Clinical targeting of the TNF and TNFR superfamilies
Croft, M., Benedict, C. A., & Ware, C. F. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3930 · Cited by 456
The role of CD40 and CD154/CD40L in dendritic cells
Ma, D. Y., & Clark, E. A. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.05.010 · Cited by 446
Sjöc;gren's Syndrome: Autoimmune Epithelitis
Moutsopoulos, H. M. (1994) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1994.1123 · Cited by 439
Clark, E. A., & Ledbetter, J. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4494 · Cited by 429
Expression of functional CD40 by vascular endothelial cells.
Hollenbaugh, D., Mischel-Petty, N., Edwards, C. P., Simon, J. C., Denfeld, R. W., Kiener, P. A., & Aruffo, A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.1.33 · Cited by 411
Fas ligation induces apoptosis of CD40-activated human B lymphocytes.
Garrone, P., Neidhardt, E. M., Garcia, E., Galibert, L., van Kooten, C., & Banchereau, J. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1265 · Cited by 390
Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion.
Spriggs, M. K., Armitage, R. J., Strockbine, L. D., Clifford, K. N., Macduff, B. M., Sato, T., Maliszewski, C. R., & Fanslow, W. C. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.6.1543 · Cited by 388
Lymphocytes in the skin of patients with progressive systemic sclerosis
Roumm, A. D., Whiteside, T. L., Medsger, T. A., & Rodnan, G. P. (1984) · Arthritis & Rheumatism · doi:10.1002/art.1780270607 · Cited by 383
Distinct Profiles of Human B Cell Effector Cytokines: A Role in Immune Regulation?
Duddy, M. E., Alter, A., & Bar-Or, A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.6.3422 · Cited by 369
Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes.
Koshy, M., Berger, D., & Crow, M. K. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118855 · Cited by 359
Sharpe, A. H. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00784.x · Cited by 357
Liu, Y.-J., Barthélémy, C., Bouteiller, O. D., Arpin, C., Isabelle, D., & Banchereau, J. (1995) · Immunity · doi:10.1016/1074-7613(95)90048-9 · Cited by 347
Treatment of multiple sclerosis — success from bench to bedside
Tintore, M., Vidal-Jordana, A., & Sastre-Garriga, J. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-018-0082-z · Cited by 343
Stuber, E., Strober, W., & Neurath, M. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.2.693 · Cited by 338
Kalunian, K. C., Davis, J. C., Merrill, J. T., Totoritis, M. C., Wofsy, D., & for the IDEC‐131 Lupus Study Group (2002) · Arthritis & Rheumatism · doi:10.1002/art.10681 · Cited by 336
Rousset, F., Garcia, E., & Banchereau, J. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.3.705 · Cited by 329
Basophils enhance immunological memory responses
Denzel, A., Maus, U. A., Gomez, M. R., Moll, C., Niedermeier, M., Winter, C., Maus, R., Hollingshead, S., Briles, D. E., Kunz-Schughart, L. A., et al. (2008) · Nature Immunology · doi:10.1038/ni.1621 · Cited by 327
Antoniades, C., Bakogiannis, C., Tousoulis, D., Antonopoulos, A. S., & Stefanadis, C. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.03.076 · Cited by 323
A central role of CD40 ligand in the regulation of CD4+ T-cell responses
Grewal, I. S., & Flavell, R. A. (1996) · Immunology Today · doi:10.1016/0167-5699(96)10030-x · Cited by 318
Immunodeficiency with hyper-IgM (HIM).
Notarangelo, L. D., Duse, M., & Ugazio, A. G. (1992) · PubMed · Cited by 308
Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States
Kitiyakara, C., Eggers, P., & Kopp, J. B. (2004) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(04)01081-9 · Cited by 303
The many roles of CD40 in cell-mediated inflammatory responses
Stout, R. D., & Suttles, J. (1996) · Immunology Today · doi:10.1016/0167-5699(96)10060-i · Cited by 280
Schattner, E. J., Elkon, K. B., Yoo, D. H., Tumang, J., Krammer, P. H., Crow, M. K., & Friedman, S. M. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1557 · Cited by 278
Gascan, H., Gauchat, J. F., Aversa, G., Van Vlasselaer, P., & de Vries, J. E. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.1.8 · Cited by 268
TRAF6 Is a Critical Factor for Dendritic Cell Maturation and Development
Kobayashi, T., Walsh, P. T., Walsh, M. C., Speirs, K. M., Chiffoleau, E., King, C. G., Hancock, W. W., Caamano, J. H., Hunter, C. A., Scott, P., et al. (2003) · Immunity · doi:10.1016/s1074-7613(03)00230-9 · Cited by 267
Danese, S., Katz, J. A., Saibeni, S., Papa, A., Gasbarrini, A., Vecchi, M., & Fiocchi, C. (2003) · Gut · doi:10.1136/gut.52.10.1435 · Cited by 257
A New Mechanism of NK Cell Cytotoxicity Activation: The CD40–CD40 Ligand Interaction
Carbone, E., Ruggiero, G., Terrazzano, G., Palomba, C., Manzo, C., Fontana, S., Spits, H., Kärre, K., & Zappacosta, S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.12.2053 · Cited by 250
Balasa, B., Krahl, T., Patstone, G., Lee, J., Tisch, R., McDevitt, H. O., & Sarvetnick, N. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.9.4620 · Cited by 244
2 å crystal structure of an extracellular fragment of human CD40 ligand
Karpusas, M., Hsu, Y.-M., Wang, J.-H., Thompson, J., Lederman, S., Chess, L., & Thomas, D. (1995) · Structure · doi:10.1016/s0969-2126(01)00239-8 · Cited by 240
Delville, M., Sigdel, T. K., Wei, C., Li, J., Hsieh, S.-C., Fornoni, A., Burke, G. W., Bruneval, P., Naesens, M., Jackson, A., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008538 · Cited by 232
Grammer, A. C., Slota, R., Fischer, R., Gur, H., Girschick, H., Yarboro, C., Illei, G. G., & Lipsky, P. E. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19301 · Cited by 230
Grammer, A. C., Slota, R., Fischer, R., Gur, H., Girschick, H., Yarboro, C., Illei, G. G., & Lipsky, P. E. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319301 · Cited by 228
Zhang, K., Clark, E. A., & Saxon, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.6.1836 · Cited by 218
Daridon, C., Devauchelle‐Pensec, V., Hutin, P., Berre, R. L., Martins-Carvalho, C., Bendaoud, B., Dueymes, M., Saraux, A., Youinou, P., & Pers, J. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22458 · Cited by 216
McKenzie, S. E., Taylor, S. M., Malladi, P., Yuhan, H., Cassel, D. L., Chien, P., Schwartz, E., Schreiber, A. D., Surrey, S., & Reilly, M. P. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.4311 · Cited by 208
Varo, N., Vicent, D., Libby, P., Nuzzo, R., Calle-Pascual, A. L., Bernal, M. R., Fernández-Cruz, A., Veves, A., Jarolim, P., Varo, J. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000074043.46437.44 · Cited by 202
Targeting CD40-induced TRAF6 signaling in macrophages reduces atherosclerosis
Seijkens, T. T. P., van Tiel, C. M., Kusters, P. J. H., Atzler, D., Soehnlein, O., Zarzycka, B., Aarts, S. A. B. M., Lameijer, M., Gijbels, M. J., Beckers, L., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.055 · Cited by 195
Lougaris, V., Badolato, R., Ferrari, S., & Plebani, A. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00229.x · Cited by 195
Absence of IgD-CD27(+) memory B cell population in X-linked hyper-IgM syndrome.
Agematsu, K., Nagumo, H., Shinozaki, K., Hokibara, S., Yasui, K., Terada, K., Kawamura, N., Toba, T., Nonoyama, S., Ochs, H. D., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3409 · Cited by 194
CD40 Signaling through Tumor Necrosis Factor Receptor-associated Factors (TRAFs)
Pullen, S. S., Dang, T. T. A., Crute, J. J., & Kehry, M. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.20.14246 · Cited by 186
McKenzie, S. E., Taylor, S. M., Malladi, P., et al. (1999) · PubMed · Cited by 184
Phenotypic models of T cell activation
Lever, M., Maini, P. K., van der Merwe, P. A., & Dushek, O. (2014) · Nature Reviews Immunology · doi:10.1038/nri3728 · Cited by 178
The effect of anti‐CD40 ligand antibody on B cells in human systemic lupus erythematosus
Huang, W., Sinha, J., Newman, J., Reddy, B., Budhai, L., Furie, R., Vaishnaw, A., & Davidson, A. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10273 · Cited by 165
Robles-Carrillo, L., Meyer, T., Hatfield, M., Desai, H., Dávila, M., Langer, F., Amaya, M., Garber, E., Francis, J. L., Hsu, Y.-M., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903888 · Cited by 164
Danese, S., Sans, M., Scaldaferri, F., Sgambato, A., Rutella, S., Cittadini, A., Piqué, J. M., Panes, J., Katz, J. A., Gasbarrini, A., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2617 · Cited by 162
Wiehagen, K. R., Girgis, N. M., Yamada, D. H., Smith, A. A., Chan, S. R., Grewal, I. S., Quigley, M., & Verona, R. I. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0258 · Cited by 162
Cooper, N., & Arnold, D. M. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08076.x · Cited by 159
CD40 Expression by human fibroblasts
Fries, K. M., Sempowski, G. D., Gaspari, A. A., Blieden, T., Looney, R. J., & Phipps, R. P. (1995) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(95)90135-3 · Cited by 158
Hydrocortisone and IL-4 induce IgE isotype switching in human B cells
Jabara, H. H., Ahern, D., Vercelli, D., & Geha, R. S. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.5.1557 · Cited by 153
The Genetic Basis of Thyroid Autoimmunity
Jacobson, E. M., & Tomer, Y. (2007) · Thyroid · doi:10.1089/thy.2007.0153 · Cited by 152
Kelsall, B. L., Stuber, E. R., Neurath, M. F., & Strober, W. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb52660.x · Cited by 151
Macrophage CD40 signaling: A pivotal regulator of disease protection and pathogenesis
Suttles, J., & Stout, R. D. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.05.011 · Cited by 146
Liu, Z., Colpaert, S. A., D’Haens, G., Kasran, A., de Boer, M., Rutgeerts, P., Geboes, K. J., & Ceuppens, J. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.4049 · Cited by 146
Davis, J. C., Totoritis, M. C., Rosenberg, J., Sklenar, T. A., & Wofsy, D. (2001) · PubMed · Cited by 146
Goules, A. V., Tzioufas, A. G., Manousakis, M., Kirou, K. A., Crow, M. K., & Routsias, J. G. (2006) · Journal of Autoimmunity · doi:10.1016/j.jaut.2006.02.002 · Cited by 144
Schultze, J. L., Michalak, S., Lowne, J., Wong, A., Gilleece, M. H., Gribben, J. G., & Nadler, L. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.1.1 · Cited by 134
The CD40-CD40L system in cardiovascular disease
Pamukçu, B., Lip, G. Y. H., Snezhitskiy, V. А., & Shantsila, E. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.546362 · Cited by 132
CD40L and Its Receptors in Atherothrombosis—An Update
Michel, N. A., Zirlik, A., & Wolf, D. (2017) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00040 · Cited by 129
Liu, Z., Geboes, K. J., Colpaert, S. A., Overbergh, L., Mathieu, C., Heremans, H., de Boer, M., Boon, L., D’Haens, G., Rutgeerts, P. J., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.11.6005 · Cited by 126
CD40-CD40L and Platelet Function: Beyond Hemostasis
Freedman, J. E. (2003) · Circulation Research · doi:10.1161/01.res.0000074030.98009.ff · Cited by 125
Facchetti, F., Appiani, C., Salvi, L., Levy, J., & Notarangelo, L. D. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.12.6624 · Cited by 123
CD40 is expressed and functional on neuronal cells
Tan, J., Town, T., Mori, T., Obregon, D., Wu, Y., DelleDonne, A., Rojiani, A. M., Crawford, F., Flavell, R. A., & Mullan, M. (2002) · The EMBO Journal · doi:10.1093/emboj/21.4.643 · Cited by 121
Lincecum, J. M., Vieira, F. G., Wang, M. Z., Thompson, K., Zutter, G. S. D., Kidd, J. D., Moreno, A., Sànchez, R., Carrion, I. J., Levine, B. A., et al. (2010) · Nature Genetics · doi:10.1038/ng.557 · Cited by 119
Increased CD40 ligand and platelet–monocyte aggregates in patients with type 1 diabetes mellitus
Harding, S. A., Sommerfield, A., Sarma, J., Twomey, P. J., Newby, D. E., Frier, B. M., & Fox, K. A. A. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.05.008 · Cited by 110
Shock, A., Burkly, L. C., Wakefield, I. D., Peters, C., Garber, E. A., Ferrant, J. L., Taylor, F. R., Su, L., Hsu, Y., Hutto, D., et al. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0757-4 · Cited by 108
Chamberlain, C., Colman, P., Ranger, A. M., Burkly, L. C., Johnston, G. I., Otoul, C., Stach, C. M., Zamacona, M. K., Dörner, T., Urowitz, M. B., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211388 · Cited by 108
Berner, B. R., Wolf, G., Hummel, K. M., Muller, G. A., & Reuss-Borst, M. A. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.3.190 · Cited by 102
The role of CD40 in CD40L- and antibody-mediated platelet activation
Amirkhosravi, A., Meyer, T. V., Siddiqui, F. A., Ahmad, S., Walker, J. M., Amaya, M., Desai, H., Francis, J. L., Länger, F. P., & Ingersoll, S. B. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-12-0774 · Cited by 100
CD40L expression permits CD8+ T cells to execute immunologic helper functions
Frentsch, M., Stark, R., Matzmohr, N., Meier, S., Durlanik, S., Schulz, A. R., Stervbo, U., Jürchott, K., Gebhardt, F., Heine, G., et al. (2013) · Blood · doi:10.1182/blood-2013-02-483586 · Cited by 100
Neutrophil CD40 enhances platelet-mediated inflammation
Vanichakarn, P., Blair, P. S., Wu, C., Freedman, J. E., & Chakrabarti, S. (2008) · Thrombosis Research · doi:10.1016/j.thromres.2007.12.019 · Cited by 100
Fc-Silent Anti-CD154 Domain Antibody Effectively Prevents Nonhuman Primate Renal Allograft Rejection
Kim, S. C., Wakwe, W., Higginbotham, L. B., Mathews, D. V., Breeden, C. P., Stephenson, A., Jenkins, J. B., Strobert, E. A., Price, K., Price, L. A., et al. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14197 · Cited by 100
An, H., Kim, Y., Song, D. H., Park, B. S., Kim, H. M., Lee, J. D., Paik, S., Lee, H., & Lee, H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.208215 · Cited by 99
Tsunawaki, S., Nakamura, S., Ohyama, Y., Sasaki, M., Ikebe‐Hiroki, A., Hiraki, A., Kadena, T., Kawamura, E., Kumamaru, W., Shinohara, M., et al. (2002) · PubMed · Cited by 99
The CD40/CD40L system: A new therapeutic target for disease
Zhang, B., Wu, T., Chen, M., Zhou, Y., Yi, D., & Guo, R. (2013) · Immunology Letters · doi:10.1016/j.imlet.2013.07.005 · Cited by 97
Clark, E. A., Grabstein, K. H., & Shu, G. L. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.11.3327 · Cited by 94
The Biological Outcome of CD40 Signaling Is Dependent on the Duration of CD40 Ligand Expression
Lee, B. O., Haynes, L., Eaton, S. M., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020845 · Cited by 93
Katsiari, C. G., Liossis, S. C., Souliotis, V. L., Dimopoulos, M. A., Manoussakis, M. N., & Sfikakis, P. P. (2002) · Clinical Immunology · doi:10.1006/clim.2001.5172 · Cited by 84
LNFPIII/LeX-Stimulated Macrophages Activate Natural Killer Cells via CD40-CD40L Interaction
Atochina, O., & Harn, D. A. (2005) · Clinical and Vaccine Immunology · doi:10.1128/cdli.12.9.1041-1049.2005 · Cited by 84
Cordoba, F., Wieczorek, G., Audet, M., Roth, L., Schneider, M. A., Kunkler, A., Stuber, N., Erard, M., Ceci, M., Baumgartner, R., et al. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13377 · Cited by 81
Schneider, R., Mohebiany, A. N., Ifergan, I., Beauseigle, D., Duquette, P., Prat, A., & Arbour, N. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100885 · Cited by 81
CD40 Ligand: A neo-inflammatory molecule in vascular diseases
Hassan, G. S., Merhi, Y., & Mourad, W. M. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.03.010 · Cited by 80
Durandy, A., Péron, S., & Fischer, A. (2006) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000231905.12172.b5 · Cited by 78
Novel Insights into Anti-CD40/CD154 Immunotherapy in Transplant Tolerance
Pinelli, D. F., & Ford, M. L. (2015) · Immunotherapy · doi:10.2217/imt.15.1 · Cited by 76
Vogel, J. D., West, G. A., Danese, S., de la Motte, C., Phillips, M. H., Strong, S. A., Willis, J. E., & Fiocchi, C. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.10.046 · Cited by 76
IL-12 Up-Regulates CD40 Ligand (CD154) Expression on Human T Cells
Peng, X., Remacle, J., Kasran, A., Huylebroeck, D., & Ceuppens, J. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1166 · Cited by 75
McDyer, J. F., Li, Z., John, S., Xiang, Y., Wu, C. Y., & Ragheb, J. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2736 · Cited by 73
Kuwana, M., Medsger, T. A., & Wright, T. M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.5.2703 · Cited by 71
Goldwater, R., Keirns, J. J., Blahunka, P. C., First, R., Sawamoto, T., Zhang, W., Kowalski, D. L., Kaibara, A., & Holman, J. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12082 · Cited by 70
Long-Term Hepatic Allograft Acceptance Based on CD40 Blockade by ASKP1240 in Nonhuman Primates
Oura, T., Yamashita, K., Suzuki, T., Fukumori, D., Watanabe, M., Hirokata, G., Wakayama, K., Taniguchi, M., Shimamura, T., Miura, T., et al. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04014.x · Cited by 69
Jin, R., Yu, S., Song, Z., Zhu, X., Wang, C., Yan, J., Wu, F., Nanda, A., Granger, D. N., & Li, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064631 · Cited by 68
CD40–CD40 Ligand Interaction Activates Proinflammatory Pathways in Pancreatic Islets
Barbé‐Tuana, F. M., Klein, D., Ichii, H., Berman, D. M., Coffey, L. C. K., Kenyon, N. S., Ricordi, C., & Pastori, R. L. (2006) · Diabetes · doi:10.2337/db05-1673 · Cited by 68
Hoves, S., Krause, S. W., Schütz, C., Halbritter, D., Schölmerich, J., Herfarth, H. H., & Fleck, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2691 · Cited by 66
Jenabian, M., Patel, M., Kema, I. P., Vyboh, K., Kanagaratham, C., Radzioch, D., Thébault, P., Lapointe, R., Gilmore, N. J., Ancuța, P., et al. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12396 · Cited by 65
Dendritic Cells Require the NF-κB2 Pathway for Cross-Presentation of Soluble Antigens
Lind, E. F., Ahonen, C. L., Wasiuk, A., Kosaka, Y., Becher, B., Bennett, K. A., & Noelle, R. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.354 · Cited by 62
Watanabe, M., Yamashita, K., Suzuki, T., Kamachi, H., Kuraya, D., Koshizuka, Y., Ogura, M., Yoshida, T., Aoyagi, T., Fukumori, D., et al. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12330 · Cited by 59
Allanore, Y., Borderie, D., Meune, C., Lemaréchal, H., Weber, S., Ekindjian, O. G., & Kahan, A. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.020040 · Cited by 59
Fukasawa, C., Kawaguchi, Y., Harigai, M., Sugiura, T., Takagi, K., Kawamoto, M., Hara, M., & Kamatani, N. (2003) · European Journal of Immunology · doi:10.1002/eji.200324088 · Cited by 58
A unique T cell subset described as CD4loCD40+ T cells (TCD40) in human type 1 diabetes
Waid, D., Wagner, R., Putnam, A. L., Vaitaitis, G. M., Pennock, N. D., Calverley, D. C., Gottlieb, P. A., & Wagner, D. H. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.05.003 · Cited by 57
Silvian, L. F., Friedman, J. E., Strauch, K., Cachero, T. G., Day, E. S., Qian, F., Cunningham, B. C., Fung, A. D., Sun, L., Su, L., et al. (2011) · ACS Chemical Biology · doi:10.1021/cb2000346 · Cited by 57
T-cell-independent Antitumor Effects of CD40 Ligation
Rakhmilevich, A. L., Alderson, K. L., & Sondel, P. M. (2012) · International Reviews of Immunology · doi:10.3109/08830185.2012.698337 · Cited by 56
Plasma levels of soluble CD40 ligand are elevated in inflammatory bowel diseases
Ludwiczek, O., Kaser, A., & Tilg, H. (2003) · International Journal of Colorectal Disease · doi:10.1007/s00384-002-0425-4 · Cited by 55
Amakata, Y., Fujiyama, Y., Andoh, A., Hodohara, K., & Bamba, T. (2001) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2001.01550.x · Cited by 55
Masuda, H., Mori, M., Uchida, T., Uzawa, A., Ohtani, R., & Kuwabara, S. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.01.024 · Cited by 55
IL-17 and CD40 ligand synergistically stimulate the chronicity of diabetic nephropathy
Kuo, H., Huang, C., Lin, T., & Lin, C. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw397 · Cited by 55
Cabral-Marques, O., Schimke, L., Pereira, P. V. S., Falcai, Â., Oliveira, J. B., Hackett, M. J., Errante, P. R., Weber, C. W., Ferreira, J. F. S., Kuntze, G., et al. (2011) · Journal of Clinical Immunology · doi:10.1007/s10875-011-9623-6 · Cited by 54
Chen, D., Ireland, S. J., Remington, G. M., Álvarez, E., Racke, M. K., Greenberg, B. M., Frohman, E. M., & Monson, N. L. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600782 · Cited by 53
Dendritic cells require NIK for CD40-dependent cross-priming of CD8 + T cells
Katakam, A. K., Brightbill, H. D., Franci, C., Kung, C., Núñez, V., Jones, C., Peng, I., Jeet, S., Wu, L. C., Mellman, I., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520627112 · Cited by 52
Autoimmune manifestations in aged mice arise from early-life immune dysregulation
Mahmoud, T. I., Wang, J., Karnell, J. L., Wang, Q., Wang, S., Naiman, B. M., Gross, P. S., Brohawn, P. Z., Morehouse, C., Aoyama, J., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aag0367 · Cited by 52
Self-citationJeppson, J. D., Patel, H. R., Sakata, N., Domenico, J. M., Terada, N., & Gelfand, E. W. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.4.1738 · Cited by 50
Increased Expression of CD40 Ligand in Activated CD4+T Lymphocytes of Systemic Sclerosis Patients
Valentini, G., Romano, M. F., Naclerio, C., et al. (2000) · Journal of Autoimmunity · doi:10.1006/jaut.2000.0387 · Cited by 45
Waid, D., Vaitaitis, G. M., Pennock, N. D., & Wagner, D. H. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1207857 · Cited by 43
Jeppson, J. D., Patel, H. R., Sakata, N., Domenico, J. M., Terada, N., & Gelfand, E. W. (1998) · PubMed · Cited by 42
Induction of human IgE synthesis in B cells by a basophilic cell line, KU812
Yanagihara, Y., 梶原, 景., Basaki, Y., et al. (1997) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1997.d01-1001.x · Cited by 41
A CD40-targeted peptide controls and reverses type 1 diabetes in NOD mice
Vaitaitis, G. M., Olmstead, M. H., Waid, D., Carter, J. R., & Wagner, D. H. (2014) · Diabetologia · doi:10.1007/s00125-014-3342-5 · Cited by 39
Small-molecule costimulatory blockade: organic dye inhibitors of the CD40–CD154 interaction
Margolles‐Clark, E., Umland, O., Kenyon, N. S., Ricordi, C., & Buchwald, P. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0519-3 · Cited by 35
Albach, F. N., Wagner, F. D., Hüser, A., Igel, J., Joseph, D. P., Hilbert, J., Schoelch, C., Padula, S. J., & Steffgen, J. (2017) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-017-2362-8 · Cited by 35
Stark, R., Hartung, A., Zehn, D., Frentsch, M., & Thiel, A. (2013) · European Journal of Immunology · doi:10.1002/eji.201243218 · Cited by 31
In vivo therapeutic efficacy of intra-renal CD40 silencing in a model of humoral acute rejection
Ripoll, È., Pluvinet, R., Torrás, J., et al. (2011) · Gene Therapy · doi:10.1038/gt.2011.39 · Cited by 31
Luheshi, N., Davies, G., Poon, E., Wiggins, K. A., McCourt, M., & Legg, J. W. (2013) · European Journal of Immunology · doi:10.1002/eji.201343351 · Cited by 31
Small-Molecule Inhibitors of the CD40–CD40L Costimulatory Protein–Protein Interaction
Chen, J., Song, Y. G., Bojadzic, D., Tamayo, A., Landin, A. M., Blomberg, B. B., & Buchwald, P. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01154 · Cited by 31
Guerrero-García, J. D. J., Rojas-Mayorquín, A. E., Valle, Y., Padilla‐Gutiérrez, J. R., Castañeda-Moreno, V. A., Mireles-Ramírez, M. A., Muñóz-Valle, J. F., & Ortuño‐Sahagún, D. (2017) · Immunobiology · doi:10.1016/j.imbio.2017.10.001 · Cited by 31
Jyothi, M. D., & Khar, A. (2000) · Cancer Immunology Immunotherapy · doi:10.1007/s002620000151 · Cited by 30
Cabral-Marques, O., Ramos, R. N., Schimke, L. F., Khan, T. A., Amaral, E. P., Bomfim, C. C. B., Reis, O., França, T. T., Arslanian, C., Lima, J. D. C. C., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.07.018 · Cited by 30
Kumar, M. S. A., Papp, K. A., Tainaka, R., Valluri, U., Wang, X., Zhu, T., & Schwabe, C. (2018) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2130 · Cited by 30
Jackaman, C., Lansley, S. M., Allan, J. E., Robinson, B. W. S., & Nelson, D. J. (2012) · International Immunology · doi:10.1093/intimm/dxs005 · Cited by 27
Shimizu, K., Asakura, M., & Fujii, S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003351 · Cited by 26
CD154 Induces Matrix Metalloproteinase‐9 Secretion in Human Podocytes
Rigothier, C., Daculsi, R., Lepreux, S., Auguste, P., Villeneuve, J., Dewitte, A., Doudnikoff, É., Saleem, M. A., Bourget, C., Combe, C., et al. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25571 · Cited by 25
CD40 Ligation Alters the Cell Cycle of Differentiating Keratinocytes
Grousson, J., Schmitt, D., Péguet‐Navarro, J., et al. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00905.x · Cited by 18
Trella, E., Raafat, N., Mengus, C., Traunecker, E., Governa, V., Heidtmann, S., Heberer, M., Oertli, D., Spagnoli, G. C., & Zajac, P. (2015) · European Journal of Immunology · doi:10.1002/eji.201545554 · Cited by 12
Cited by
B cell depletion therapies in autoimmune disease: advances and mechanistic insights
Lee, D. S. W., Rojas, O. L., & Gommerman, J. L. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00092-2 · Cited by 658
Kinase inhibition in autoimmunity and inflammation
Zarrin, A. A., Bao, K., Lupardus, P., & Vucic, D. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0082-8 · Cited by 431
Song, Y., Li, J., & Wu, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01952-8 · Cited by 259
Inhibition of CD40L with frexalimab in multiple sclerosis
Vermersch, P., Granziera, C., Mao-Draayer, Y., Cutter, G., Kalbus, O., Staikov, I., Dufek, M., Saubadu, S., Bejuit, R., Truffinet, P., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2309439 · Cited by 102
Small molecules targeting protein–protein interactions for cancer therapy
Wu, D., Li, Y., Zheng, L., Xiao, H., Ouyang, L., Wang, G., & Sun, Q. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.05.035 · Cited by 71
Metadata
- Authors
- Karnell, J. L., Rieder, S. A., Ettinger, R., & Kolbeck, R.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 141
- Pages
- 92-103
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2904526367
- Cited by
- 334
- References
- 148
- FWCI
- 2.27
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.